CG Oncology, Inc. Common stock (CGON) short interest & short volume · 13.5% of float short
CG Oncology, Inc. Common stock official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
CGON short interest fell 15.0% to 8.9M shares in the Oct 15, 2026 report (13.5% of float, 9.7 days to cover). Daily short volume averaged 69.6% of volume over the last 20 sessions, up from 55.1% the 20 sessions before, the 100th percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 8.9M
- prior 10.4M
- % of float
- 13.5%
- float 65.8M
- Days to cover
- 9.7
- avg vol 919K
- Change vs prior report
- -15.0%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 76.9%
- 323K of 420K
- 20-day average
- 69.6%
- prior 55.1%
- Percentile vs own history
- 100th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: +3.6%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
CGON's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · CGON overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 322,733 | 419,667 | 76.9% |
| 2026-10-30 | 295,697 | 362,648 | 81.5% |
| 2026-10-29 | 67,682 | 90,661 | 74.7% |
| 2026-10-28 | 185,154 | 206,949 | 89.5% |
| 2026-10-27 | 137,099 | 197,470 | 69.4% |
| 2026-10-26 | 159,956 | 199,913 | 80.0% |
| 2026-10-23 | 114,701 | 284,694 | 40.3% |
| 2026-10-22 | 205,800 | 247,256 | 83.2% |
| 2026-10-21 | 109,315 | 174,165 | 62.8% |
| 2026-10-20 | 120,584 | 215,380 | 56.0% |
Healthcare peers with similar quant ratings
CGON is rated 1.25 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- GPCR short interest1.28 · Strong Sell · stock
- NUVB short interest1.27 · Strong Sell · stock
- SPRY short interest1.27 · Strong Sell · stock
- CADL short interest1.26 · Strong Sell · stock
- ANNX short interest1.24 · Strong Sell · stock
- VKTX short interest1.24 · Strong Sell · stock
- RCUS short interest1.23 · Strong Sell · stock
- IMNM short interest1.22 · Strong Sell · stock
CGON short interest FAQ
What is CGON's short interest?
CG Oncology, Inc. Common stock (CGON) had 8.9M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 13.5% of its 65.8M-share float.
How many days to cover does CGON have?
9.7 days: 8.9M shares short divided by an average daily volume of 919K for the Oct 15, 2026 period.
Is CGON short interest rising or falling?
CGON short interest fell (-15.0%) from 10.4M to 8.9M shares in the Oct 15, 2026 report.
Is CGON a short squeeze candidate?
Lician's squeeze watch scores CGON 45 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 18/40, days to cover 24.1/25, change in short interest vs prior report 0/15, price change since settlement date 2.9/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of CGON daily volume is sold short?
69.6% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 100th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was CGON's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for CG Oncology, Inc. Common stock (CGON) was 322,733 shares, 76.9% of 419,667 total volume.
How many CGON short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for CG Oncology, Inc. Common stock (CGON), from Oct 20, 2026 through Nov 2, 2026.
How did CGON short volume percent change from the prior cached session?
Cached FINRA short volume for CG Oncology, Inc. Common stock (CGON) moved from 81.5% on Oct 30, 2026 to 76.9% on Nov 2, 2026, down 4.6 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.